Advertisement

Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x100px
Organisation › Details

Merck China Biologics Testing Center (Shanghai)

In September 2022 Merck opened a viral clearance (VC) laboratory as part of the first building phase of its new € 29 million China Biologics Testing Center. The 5,000 square meter center is the first of its kind for Merck in China. The VC laboratory allows customers to locally conduct viral clearance studies from pre-clinical development to commercialization and will meet the double-digit demand for VC testing services in China.1 The VC laboratory will add around 120 jobs by 2023. The first building phase of the center adds laboratory capacity for viral clearance studies, one of the most critical steps in drug development. These studies are key to supporting the Investigational New Drug (IND) and Biologics License Application (BLA) filing milestones, which are required by regulatory agencies around the world to complete clinical trials and move to commercial manufacturing. The second phase of the center’s facilities will open in late 2023 and will offer cell line characterization and lot release testing services. The facility in Shanghai joins Merck’s global viral clearance suites network with sites in Singapore; Stirling, UK; and Rockville, Maryland, USA, and shares the same global expertise, standards, and operating systems. *

 

Period Start 2022-09-21 start
  Group Merck (DE) (Group)
Products Industry BioReliance® End-to-End Solutions
  Industry 2 drug development services
     
Region Region Shanghai
  Country China
  City n. a. Shanghai
    Address record changed: 2022-09-25
     
Basic data Employees n. a.
     
    * Document for »About Section«: Merck KGaA. (9/21/22). "Press Release: Merck Opens New € 29 Million Biologics Testing Center in Shanghai". Shanghai.
     
   
Record changed: 2023-12-06

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Merck (DE) (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Stier Group MIXiii Lifescience Healthtech Conference 650x300px




» top